PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $15,602,000 | -27.2% | 7,359,385 | +15.0% | 0.00% | -25.0% |
Q3 2016 | $21,445,000 | +13.9% | 6,401,415 | +6.7% | 0.00% | 0.0% |
Q2 2016 | $18,830,000 | -4.3% | 5,996,693 | +1.5% | 0.00% | -20.0% |
Q1 2016 | $19,682,000 | -55.3% | 5,910,486 | -52.5% | 0.01% | -50.0% |
Q4 2015 | $44,026,000 | -31.1% | 12,436,795 | -2.0% | 0.01% | -41.2% |
Q3 2015 | $63,861,000 | -23.4% | 12,696,043 | -2.1% | 0.02% | -15.0% |
Q2 2015 | $83,369,000 | -11.3% | 12,965,652 | -3.0% | 0.02% | -9.1% |
Q1 2015 | $94,015,000 | -0.9% | 13,363,921 | +8.6% | 0.02% | -4.3% |
Q4 2014 | $94,863,000 | +10.0% | 12,303,913 | +6.6% | 0.02% | -4.2% |
Q3 2014 | $86,231,000 | -21.7% | 11,543,595 | +1.4% | 0.02% | -22.6% |
Q2 2014 | $110,199,000 | +15.2% | 11,384,180 | -1.1% | 0.03% | +10.7% |
Q1 2014 | $95,661,000 | +4.7% | 11,511,495 | +6.3% | 0.03% | 0.0% |
Q4 2013 | $91,365,000 | +7.9% | 10,825,279 | +1.8% | 0.03% | -3.4% |
Q3 2013 | $84,711,000 | +10.8% | 10,628,790 | +7.3% | 0.03% | +3.6% |
Q2 2013 | $76,473,000 | – | 9,905,848 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |